Table 3.
Toxicity | Duration of Follow-Up |
|||||
---|---|---|---|---|---|---|
6 Months |
12 Months |
24 Months |
||||
OR* | P† | OR* | P† | OR* | P† | |
Diagnostic procedures to investigate incontinence or obstruction | 1.80 | < .001 | 1.64 | < .001 | 2.23 | < .001 |
Urethritis, urethral strictures, and bladder outlet obstruction | 1.25 | .14 | 1.45 | .002 | 1.78 | < .001 |
Therapeutic procedures to correct urinary incontinence | 0.71 | .22 | 1.00 | 1.00 | 1.33 | .09 |
Other genitourinary toxicity | 0.77 | .45 | 1.14 | .58 | 0.73 | .23 |
Infections | 1.01 | .99 | 2.30 | .11 | 2.42 | .15 |
Erectile dysfunction | 1.46 | .03 | 1.15 | .28 | 1.13 | .35 |
Abbreviation: OR, odds ratio.
Stereotactic body radiation therapy compared with intensity-modulated radiation therapy.
P values are from adjusted random effects logit model based on the Šidák correction for multiple comparisons; P < .003 is significant (significant values shown in bold).